BioSpace News Archive

NanoImaging Services (“NIS”), launches new cryo-transmission electron microscopy (“cryo-TEM”) services to support biologics characterization with full GMP compliance.

GT Biopharma, Inc. today announced second quarter 2023 results for the period ended June 30, 2023.

In a groundbreaking development, India-based company Voxelgrids has launched an advanced and affordable MRI scanner with the potential to revolutionize healthcare accessibility not only in India but also worldwide.

Genomma Lab Internacional, S.A.B. de C.V. announced that the Mexican Ministry of Health’s Federal Committee for Protection from Sanitary Risks has granted its approval of the sanitary license for the oral liquids, topical liquids and tablet coatings operations at Genomma Lab’s Medicinas y Medicamentos Nacionales, S.A. de C.V. manufacturing facility in the State of Mexico.

Vincerx Pharma, Inc. today reported financial results for the second quarter ended June 30, 2023 and provided a corporate update.

Stericycle, Inc., a leading provider of regulated medical waste management and secure information destruction solutions, announced that Janet Zelenka, chief financial officer and chief information officer, was named to the 2023 Crain’s Chicago Business Notable Leaders in Finance list.

CareDx, Inc. announced that the United States District Court for the District of Delaware issued an injunction prohibiting Natera from continuing to falsely advertise and overstate the scientific performance of its Prospera transplant test.

A report by Precedence Research examines the cell culture media market size is predicted to hit around USD 16.84 billion by 2032 and is growing at a CAGR of 11.89% from 2023 to 2032.

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. Food and Drug Administration (FDA) approval of its therascreen PDGFRA RGQ PCR kit (therascreen PDGFRA kit).

FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the second quarter 2023 and provided an update on the Company’s recent developments.